✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Gujarat Themis Biosyn Ltd.

GUJTHEM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹4,273 Cr.
P/E
95.80

Gujarat Themis Biosyn Ltd.

  • Guj. Themis Biosyn
  • Concord Biotech
  • Medicamen Biotech
FAQs on Gujarat Themis Biosyn Ltd. Shareprice

Guj. Themis Biosyn has given better returns compared to its competitors.
Guj. Themis Biosyn has grown at ~92.15% over the last 2yrs while peers have grown at a median rate of 16.3%

Yes, Guj. Themis Biosyn is expensive.
Latest PE of Guj. Themis Biosyn is 94.38, while 3 year average PE is 33.83.
Also latest EV/EBITDA of Guj. Themis Biosyn is 65.81 while 3yr average is 24.78.

View FAQ's On Business
Growth Table
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Balance Sheet
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Cash Flow
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Quarterly Results
  • Gujarat Themis Biosyn Ltd.
  • Concord Biotech
  • Medicamen Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Gujarat Themis Biosyn Ltd. Financials

Balance sheet of Guj. Themis Biosyn is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Guj. Themis Biosyn is increasing.
Latest net debt of Guj. Themis Biosyn is ₹4.8 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹16.31 Crs.

No, profit is decreasing.
The profit of Guj. Themis Biosyn is ₹44.6 Crs for TTM, ₹48.77 Crs for Mar 2025 and ₹59.16 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Guj. Themis Biosyn latest dividend payout ratio is 14.97% and 3yr average dividend payout ratio is 13.59%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech